The overall occurrence of nausea did not differ significantly between those treated with SYK and/or BTK inhibitors and those receiving placebo (RR 1.45; 95%CI: 0.84 – 2.51, p=0.18, I2 = 23%, random-effect model) (Table 3). This evidence concerns the gene BTK and Nausea.